Tempus Priority Study: A Pan-tumor Observational Study
Public ClinicalTrials.gov record NCT05179824. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Tempus Priority Study: An Observational Study of Patients Who Have Received Comprehensive Genomic Profiling
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Observational study that will be collecting clinical and molecular health information from cancer patients who have received comprehensive genomic profiling and meet the specific eligibility criteria outlined for each cohort with the goal of conducting research to advance cancer care and create a dataset that furthers cancer research.
Study identification
- NCT ID
- NCT05179824
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,000 participants
Conditions and interventions
Conditions
- Breast Cancer
- Prostate Cancer
- Bladder Cancer
- Lung Cancer
- Brain Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Fallopian Tube Cancer
- Peritoneal Cancer
- Cancer of Liver
- Cancer of Colon
- Cancer of Head and Neck
- Cancer of Stomach
- Cancer of Gastrointestinal Tract
- Cancer of Rectum
- Cancer of Esophagus
- Cancer of Skin
- Cancer of Cervix
- Cancer of Kidney
- Cancer of Larynx
- Cancer of Endometrium
- Cancer of the Bile Duct
- Cancer of Vulva
- Cancer of Bone and Connective Tissue
- Leukemia
- Lymphoma
- Spinal Cord Cancer
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 18, 2020
- Primary completion
- Oct 18, 2026
- Completion
- Oct 18, 2030
- Last update posted
- May 5, 2025
2020 – 2030
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UT Southwestern | Dallas | Texas | 75390 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05179824, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 5, 2025 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05179824 live on ClinicalTrials.gov.